Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest androgenetic alopecia Stories

Researchers Uncover Clue To Baldness, Could Lead To Cure
2012-03-22 09:08:22

Male baldness, long considered the bane of men all over the world, may become a thing of the past after researchers found a biological clue that could raise the prospect of stopping and perhaps even reversing hair loss. The researchers, from University of Pennsylvania's Perelman School of Medicine, have identified an abnormal amount of protein called Prostaglandin D2 (PGD2) in the bald scalp of men with male pattern baldness. Lab studies were conducted using mice and cultured human hair...

2012-03-15 11:58:22

Spanish scientists have confirmed that there is a clear relationship between androgenetic alopecia (common premature baldness) and benign prostate hyperplasia (BPH), a benign enlargement of the prostate that appears in aging men and is associated with certain hormones as dihydrotestosterone. This condition appears in 50% of men over 60 year old and causes voiding syndrome i.e. urinary frequency. In the light of the study published in the journal of the American Academy of Dermatology, men...

2011-11-03 07:00:00

An analysis undertaken to assess the safety and efficacy of the HairMax LaserComb from 6 double blind clinical studies with 460 subjects found that no serious side effects occurred in any of these studies which proved the efficacy of the device in treating androgenetic alopecia (hereditary hair loss) in men and women. This analysis combined with the fact that there have never been any reports of serious side effects occurring in the over 10 years the HairMax has been on the market,...

2011-10-21 07:00:00

Lexington Int'l announces that FDA Marketing Clearance has been granted for the HairMax Advanced 7 and Professional 12 models, for the treatment of androgenetic alopecia (hereditary hair loss) in females.This latest milestone is the culmination of Lexingtonâs goal to offer a complete line of innovative, cutting edge, phototherapy devices for treating hereditary hair loss in men and women around the world. Boca Raton, FL (PRWEB) October 21, 2011 Lexington International, LLC, is...

2011-04-21 08:00:00

BOCA RATON, Fla., April 21, 2011 /PRNewswire/ -- Lexington International, LLC is pleased to announce that it has successfully completed 2 clinical studies of the HairMax LaserComb proving the efficacy and safety of 3 new devices for the treatment of androgenetic alopecia (hereditary hair loss). The analysis showed that 95.4% of participants using the HairMax LaserComb experienced hair growth. Furthermore, the average increases in hair count for participants in the HairMax LaserComb group...

2011-01-24 03:43:00

TOKYO, Jan. 24, 2011 /PRNewswire/ -- R-Tech Ueno, Ltd. is pleased to announce that the Phase 2a clinical study of RK-023 to treat androgenetic alopecia (note 1) was completed by January 21, 2011. Our company focuses on the area of no topical prescription drug in the market of androgenetic alopecia treatment and has developed a new topical drug. The Phase 2a clinical study of RK-023 for androgenetic alopecia treatment was performed in 48 patients with mild-to-moderate androgenetic alopecia,...

2009-07-21 01:27:00

TOKYO, July 21 /PRNewswire/ -- R-Tech Ueno, Ltd. announced on July 17 that as a phase 1 clinical study on the new compound RK-023 that is being developed by our company as a therapeutic drug of androgenetic alopecia (male pattern baldness; see the note below) has been completed. The phase 1 clinical study of RK-023 consisted of a patch test (open, closed, photo-patch test), single-dose study and 5-day repeated-dose study. Since no serious adverse event occurred in each test, RK-023 seems to...

2008-10-07 12:00:52

Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC (www.hairdx.com), today announced that it has received institutional review board (IRB) approval to begin a clinical trial of a genetically tailored therapy for female baldness (Androgenetic Alopecia). "Our goal is to revolutionize the field of dermatology by innovating genetically tailored treatments to common skin disorders," said Andy Goren, Chairman and Chief Strategist of PharmaGenoma,...

2007-08-30 06:19:04

By Verdier-Sevrain, S ABSTRACT Estrogens have a profound influence on skin. The relative hypoestrogenism that accompanies menopause exacerbates the deleterious effects of both intrinsic and environmental aging. Estrogens prevent skin aging. They increase skin thickness and improve skin moisture. Beneficial effects of hormone replacement therapy (HRT) on skin aging have been well documented, but HRT cannot obviously be recommended solely to treat skin aging in menopausal women. Topical...